We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s Center for Drug Evaluation and Research (CDER) has issued draft guidance for industry on developing medicines that can be used for the treatment of celiac disease (CeD) along with a gluten-free diet. Read More
The Federal Trade Commission (FTC) is extending the public comment period by a month on a request for information centering on the business practices of pharmacy benefit managers (PBMs). Read More